Apyx Medical Corporation (APYX) — Analyst outlook / Analyst consensus target is. Based on 9 analyst ratings, the consensus is bullish — 8 Buy, 1 Hold.
The consensus price target is $6.00, representing an upside of 56.3% from the current price $3.84.
Analysts estimate Earnings Per Share (EPS) of $-0.71 and revenue of $0.05B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.66 vs est $-0.71 (beat +6.4%). 2025: actual $-0.27 vs est $-0.30 (beat +11%). Analyst accuracy: 90%.
APYX Stock — 12-Month Price Forecast
$6.00
▲ +56.25% Upside
Average Price Target
Based on 9 Wall Street analysts offering 12-month price targets for Apyx Medical Corporation, the price target is $6.00.
The average price target represents a +56.25% change from the last price of $3.84.
APYX Analyst Ratings
Buy
Based on 9 analysts giving stock ratings to Apyx Medical Corporation in the past 3 months
EPS Estimates — APYX
90%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.66
vs Est –$0.71
▲ 6.9% off
2025
Actual –$0.27
vs Est –$0.30
▲ 12.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — APYX
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.048B
vs Est $0.047B
▲ 1.7% off
2025
Actual $0.053B
vs Est $0.052B
▲ 1.2% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
